Navigation Links
Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
Date:4/11/2008

(average CMI = 438 ng/mL ATP) than the average measure among patients showing no signs of rejection (average CMI = 301 ng/mL ATP; p = 0.05).

The analysis also looked at the incidence of infections among the study population. A total of 30 infections were identified in patients with low CMI (<225 ng/mL ATP; based on 57 assays) as compared to only eight infections in patients with moderate or strong CMI (>225 ng/mL ATP; based on 113 assays). The average CMI in samples from patients with infection was 119 ng/mL ATP as compared to 336 ng/mL ATP in samples from patients with no sign of infection (p < 0.001). Identified infections included 13 with a viral etiology; 15 with bacterial etiology; and 10 with fungal etiology.

"Immune function monitoring of adult heart transplant patients using the ImmuKnow assay may have the potential to aid in the assessment of the immune status of the patient and the patient's risk for organ rejection or infection," concluded Dr. Kobashigawa. "We are currently conducting clinical studies using these data to manage immunosuppression in our heart transplant patients, with the goal of limiting risk for rejection and infection."

Dr. Kobashigawa's presentation was entitled, "Success of immune monitoring with ImmuKnow (Cylex(TM)) to assess rejection/infectious risk in heart transplantation." Dr. Kobashigawa is Clinical Professor of Medicine and Chief of the Division of Clinical Faculty Medicine at David Geffen School of Medicine at UCLA. He is also Medical Director of the UCLA Heart Transplant Program.

About ImmuKnow(R)

ImmuKnow is an immune cell function assay that can detect cell-mediated immunity (CMI) in adult immunosuppressed patients by measuring the concentration of adenosine triphosphate (ATP) released from CD4 cells following cell stimulation.

The ImmuKnow test is a qualitative assay and does not directly quantify the level of immunosuppression. Results of ImmuKnow assays should be used in conjunc
'/>"/>

SOURCE Cylex Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
2. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
3. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
4. Seneca Valley High School Student Receives Science Award From MedImmune
5. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
6. AutoImmune Inc. Reports 2007 Fourth Quarter and Year End Financial Results
7. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
8. Immune system protein starves staph bacteria
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. MedImmune Submits Biologics License Application to FDA for Motavizumab
11. Peptimmune Announces First Close of Series D Private Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Quebec , November 21, 2014 ... como responsable comercial   Mariano Rodríguez es ...   KLOX está en marcha para comenzar ... de cura de heridas de reciente aprobación en Europa   ... "la compañía") se complace al anunciar los siguientes nombramientos: ...
(Date:11/21/2014)... Author Matthew J. Pallamary’s second short story ... published as a tribute to his mentor Ray ... Story” category of the 2014 USA Best Book ... USA Book News, said this year’s contest yielded over ... & Schuster, Penguin, John Wiley & Sons, Houghton Mifflin ...
(Date:11/21/2014)... 2014 BlueInGreen, LLC ( BlueInGreen® ... (Pinnacle), and PCI, Inc., leading suppliers of ozone ... been selected to provide a new state-of-the-art ozone ... R. Noland Wastewater Treatment. The new ozone ... gas dissolution technology, Pinnacle Ozone’s industry leading ...
(Date:11/21/2014)... Nov. 20, 2014 Polaris Group announced ... in its Phase 1 trial of ADI-PEG 20 ... treatment of malignant pleural mesothelioma (MPM) and non-squamous ... clinical trials on ADI-PEG 20, both as monotherapy ... treatment of several other indications, including breast cancer, ...
Breaking Biology Technology:KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
... Iowa, Dec. 18 - DuPont today congratulated,growers planting ... of,the 15 national categories in the 2007 National ... these growers won with Pioneer sorghum,hybrid 84G62., ... in all,five national contest segments. First-, second- and ...
... PALO ALTO, Calif., Dec. 18 CV Therapeutics,Inc. ... U.S. Food and Drug,Administration (FDA) has approved new ... tablets) which describes the ability,of ranolazine to inhibit ... Published data on ranolazine,s mechanism suggests that during ...
... Md., Dec. 18 Panacea Pharmaceuticals, lung,cancer ... one of Time Magazine,s,Ten Biggest Medical Breakthroughs ... please cut,and paste into browser:, http://www.time.com/time/specials/2007/top10/article/0,30583,1686204_1686252_1690390, ,00.html) ... to facilitate the identification,of lung cancer, even ...
Cached Biology Technology:DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest 2FDA Approves New Mechanism of Action Labeling for Ranexa(R) 2Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 2Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 3Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007 4
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/11/2014)... 2014  Forensicon, Inc., a Chicago ... announce the promotion of Yaniv Schiff from ... In Schiff,s new role as Director, he will lead ... forensics examiners and provide leadership within the company,s digital ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon in ...
(Date:11/7/2014)... Nov. 7, 2014  In conjunction with the ... Departments, The Community Foundation of the Verdugos has announced the ... JUSTICE PROJECT," a $250,000 initiative to keep the Verdugo Regional ... its first six months of existence, the Lab has processed ... for local law enforcement. "Because our number one ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... "It,s in their genes" is a common refrain from ... age 100 and beyond. Up until now, research has ... as high levels of HDL ("good") cholesterol. But researchers at ... Graduate School of Psychology of Yeshiva University have found ...
... have discovered that some hardy species can survive the ... submersible rises to the surface. The team,s findings, published ... can be inadvertently carried by submersibles to new areas, ... using the manned submersible Alvin to collect samples of ...
... DURHAM, N.C. Women receiving care for breast ... for years after they have completed treatment, according to ... Center. The findings, reported online in the ... that poor cardio-pulmonary function may be a strong predictor ...
Cached Biology News:'Personality genes' may help account for longevity 2Deep sea animals stowaway on submarines and reach new territory 2Cardio fitness levels of breast cancer patients may affect survival 2
... cell and PowerPac basic power supply are used ... in agarose gels. The mini format cell includes ... and leveling bubble. The PowerPac basic power supply, ... V, 4-400 mA, and 75 W. Power cord ...
... The Sequi-Gen GT and PowerPac 3000 system, ... using a 38 x 30 cm vertical slab ... GT electrophoresis cell, which is capable of separating ... an integral plate chamber (IPC) assembly (IPC and ...
... Paragon CZE 2000 Capillary Electrophoresis System ... serum protein electrophoresis (SPE), urine protein ... fast and accurate analysis. The system ... sample preparation and no staining to ...
The filter 640DF35 for the Molecular Imager FX is a band pass filter for Texas Red dye....
Biology Products: